CF PharmTech Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Bill Wenqing

Chief executive officer

CN¥2.6m

Total compensation

CEO salary percentage	27.76%
CEO tenure	12.8yrs
CEO ownership	n/a
Management average tenure	8.3yrs
Board average tenure	5.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bill Wenqing's remuneration changed compared to CF PharmTech's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2025	n/a	n/a	CN¥28m
Dec 31 2024	CN¥3m	CN¥732k	CN¥21m
Dec 31 2023	CN¥2m	CN¥699k	CN¥32m
Dec 31 2022	CN¥5m	CN¥671k	-CN¥49m

Compensation vs Market: Bill's total compensation ($USD370.18K) is about average for companies of similar size in the Hong Kong market ($USD455.83K).

Compensation vs Earnings: Bill's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Bill Wenqing (59 yo)

12.8yrs

Tenure

CN¥2,637,000

Compensation

Dr. Liang Wenqing, also known as Bill, Co-Founder of CF PharmTech, Inc. and serves as its Executive Chairperson and serves as its Chief Executive Officer and Director since January 24, 2013. In addition to...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Liang Wenqing	Co-Founder	12.8yrs	CN¥2.64m	no data
Li Li Bovet	Co-Founder	12.8yrs	CN¥2.52m	no data
Li Qi	COO & Executive Director	8.2yrs	CN¥1.30m	no data
Zhu Yuyu	Deputy GM	8.4yrs	CN¥924.00k	no data
Wei Wei	Head of Finance	3.3yrs	no data	no data
Cheuk Ting Chu	Joint Company Secretary	less than a year	no data	no data

8.3yrs

Average Tenure

52.5yo

Average Age

Experienced Management: 2652's management team is seasoned and experienced (8.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Liang Wenqing	Co-Founder	12.8yrs	CN¥2.64m	no data
Li Li Bovet	Co-Founder	12.8yrs	CN¥2.52m	no data
Li Qi	COO & Executive Director	5.1yrs	CN¥1.30m	no data
Zhu Yuyu	Deputy GM	5.1yrs	CN¥924.00k	no data
Penghui Chen	Non-Executive Director	5.3yrs	no data	no data
Lei Cai	Non-Executive Director	5.8yrs	no data	no data
Shirong Wei	Independent Non-Executive Director	5.1yrs	CN¥60.00k	no data
Hua Yi	Non-Executive Director	3.8yrs	no data	no data
Wang Lijuan	Independent Non-Executive Director	5.1yrs	CN¥60.00k	no data
Jin Jian	Independent Non-Executive Director	5.1yrs	CN¥60.00k	no data
Zhang Jingjing	Chairperson of the Supervisors	3.9yrs	no data	no data
Wang Hoi Ip	Independent Non-Executive Director	1.1yrs	no data	no data

5.1yrs

Average Tenure

56yo

Average Age

Experienced Board: 2652's board of directors are considered experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/22 06:38
End of Day Share Price	2025/10/22 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CF PharmTech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.